US Patent Issued to JDS Therapeutics on July 21 for "GLP-1R agonist and DPP-4 inhibitor compositions and methods of using" (New York, Georgia, Connecticut Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,713, issued on July 21, was assigned to JDS Therapeutics LLC (Harrison, N.Y.).

"GLP-1R agonist and DPP-4 inhibitor compositions and methods of using" was invented by James R. Komorowski (Trumbull, Conn.), Devon Bernsley (New York) and Sophia Ramirez (Marietta, Ga.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compositions comprising a GLP-1R agonist composition, a DPP-4 inhibitor composition, or a combination of both. The description contained herein describes methods for inducing weight loss and/or boosting satiety in a subject. The compositions described herein may be formulated for oral administration, and in some embodiment...